LPA and atherosclerosis: The discovery of lipoprotein(a) [(Lp(a)], and the fact that elevated Lp(a) is an independent risk factor for atherosclerosis and CVD, directed the research to find drugs which might decrease its levels in serum and therefore could prevent cardiovascular events in patients with elevated Lp(a) levels.